血中的α-Synuclein形状区分了帕金森病与患有勒维体痴呆症的帕金森病
George T Kannarkat1, Rebecca Zack1, R Tyler Skrinak1
1Department of Neurology, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA, 19104.
Research square
|October 7, 2024
概括
新的研究揭示了血中明显的α-synuclein (aSyn) 菌株,将帕金森病 (PD) 与患有莱维体 (DLB) 痴呆症区分开来,并预测PD的认知衰退.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 错误折叠的α-synuclein (aSyn) 聚合定义了勒维体疾病 (LBD),包括帕金森病 (PD) 和勒维体痴呆症 (DLB).
- 存在不同的aSyn"菌株"具有不同的生物特性,但缺乏PD与DLB的特定生物标志物.
- 识别LBD亚型的可靠生物标志物和了解aSyn菌株的作用对于诊断和治疗至关重要.
研究的目的:
- 调查特定的α-synuclein (aSyn) 菌株作为生物标志物的潜力,以区分帕金森病 (PD) 和患有莱维体 (DLB) 的痴呆症.
- 探索人类生物流体 (血和脑脊液) 中不同aSyn物种的存在和水平,以及它们与LBD亚型的相关性.
- 评估血aSyn菌株对PD患者认知衰退的预测价值.
主要方法:
- 用两种单克隆抗体向不同的aSyn*体外物种 (A菌株和B菌株) 进行分析.
- 人类血和脑脊液 (CSF) 中量化A菌株和B菌株aSyn水平,来自PD和DLB患者的独立队列.
- 在体外评估了血aSyn物种对模板aSyn纤维化的能力.
主要成果:
- 在两个独立的队列中,PD和DLB个体之间的A菌株和B菌株aSyn物种的血水平显著不同.
- 发现较低水平的血aSyn Strain A物种可以预测PD患者随后的认知衰退.
- 虽然aSyn菌株在脑脊液中无法检测到,但血aSyn物种表现出模板aSyn纤维化的能力,特别是在PD样本中.
结论:
- 基于血检测不同的α-synuclein (aSyn) 菌株 (A和B) 可以区分帕金森病 (PD) 和患有莱维体 (DLB) 的痴呆症.
- 血aSyn菌株A水平可能作为PD认知衰退的预测生物标志物.
- 这些发现表明,aSyn菌株可能会影响LBD的临床表现,并可能来自大脑以外的来源.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.5K
相关概念视频
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Parkinson's Disease: Treatment
233
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
233
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
